NIMH Clinical Pathway for Suicide Prevention
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the NIMH Clinical Pathway treatment for suicide prevention?
Research shows that clinical pathways, which are structured plans of care, can improve treatment outcomes in psychiatric settings, such as for depression. These pathways help ensure that care is consistent and based on the best available evidence, which can be beneficial in managing conditions like suicidality.12345
What safety data exists for the NIMH Clinical Pathway for Suicide Prevention?
The NIMH guidelines for managing suicidal risk in clinical trials include procedures to detect, monitor, and manage suicidal subjects, as demonstrated in the STAR*D study. However, there is a lack of clear and consistent definitions and reporting of adverse events, which makes evaluating the safety of interventions challenging.16789
How is the NIMH Clinical Pathway treatment for suicide prevention different from other treatments?
The NIMH Clinical Pathway for suicide prevention is unique because it uses a structured approach to assess and manage suicidality, focusing on evidence-based guidelines and comprehensive procedures to monitor and reduce suicide risk, unlike traditional treatments that may not have such a systematic framework.125810
What is the purpose of this trial?
This study will adapt and evaluate an evidence-based suicide risk screening and follow-up program in two school-based health centers in West Virginia. The suicide screening program is titled the "NIMH Clinical Pathway" and provides tools and procedures for routinely screening adolescents for suicide risk, completing risk assessments, safety planning, lethal means restriction, follow-up referrals, and other disposition planning as appropriate.Investigators aim to do the following:1. Gather formative data from providers, parents, and youth to inform ways to adapt and implement the NIMH Clinical Pathway so that it can be effectively implemented in rural, Appalachian School-Based Health Centers (SBHCs).2. Gather preliminary data regarding the feasibility, acceptability, and effectiveness of the adapted intervention.
Research Team
Mary Christensen, PhD, LICSW
Principal Investigator
West Virginia University
Eligibility Criteria
This trial is for adolescents attending school-based health centers in West Virginia. It's focused on those who may be at risk of suicide and can benefit from routine screening and follow-up care. The study seeks input from providers, parents, and youth to tailor the program effectively.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of the NIMH Clinical Pathway for routine suicide risk screening, assessment, safety planning, and follow-up
Follow-up
Participants are monitored for safety and effectiveness after intervention, including follow-up appointments to re-assess suicidal symptoms
Treatment Details
Interventions
- NIMH Clinical Pathway
Find a Clinic Near You
Who Is Running the Clinical Trial?
West Virginia University
Lead Sponsor